How Much Did Biomilq Raise?
Funding & Key Investors

Biomilq has successfully secured a total of $24.5M in capital to advance its proprietary cell-cultured human milk technology. This latest infusion of $21M marks a significant milestone in the company's growth trajectory, signaling strong investor confidence in its mission to redefine infant nutrition through science-led innovation. By leveraging this strategic financing, the firm is well-positioned to transition from laboratory-scale development to more robust operational frameworks, addressing the critical demand for diverse infant feeding solutions in the global market.

What is Biomilq?

Biomilq
ManufacturingFood & Beverage

Biomilq operates at the intersection of biotechnology and food science, functioning as a woman-owned, science-led startup dedicated to the production of human milk outside the body. The company utilizes advanced cell-culture techniques to replicate the nutritional profile of breast milk, providing parents with a sustainable and biologically relevant alternative. By focusing on the intersection of maternal health and infant development, Biomilq is carving out a unique niche within the broader food technology sector, effectively challenging traditional infant formula paradigms with a focus on cellular agriculture and nutritional precision.

How much funding has Biomilq raised?

Biomilq has raised a total of $24.5M across 2 funding rounds:

2020

Angel/Seed

$3.5M

2021

Series A

$21M

Angel/Seed (2020): $3.5M with participation from Breakthrough Energy Ventures

Series A (2021): $21M, investors not publicly disclosed

Key Investors in Biomilq

Breakthrough Energy Ventures

A prominent venture capital firm backed by global business leaders, specializing in funding transformative clean energy and sustainable technology companies that aim to achieve net-zero emissions.

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Biomilq?

With the recent capital injection, Biomilq is expected to accelerate its research and development efforts, focusing on scaling its production technology and navigating the complex regulatory landscape associated with novel food products. The company's strategic roadmap likely includes expanding its laboratory infrastructure and conducting rigorous safety and efficacy trials to ensure its product meets the highest standards for infant health. As the firm moves beyond its Series A phase, the focus will shift toward commercialization readiness and establishing supply chain partnerships that can support the eventual market entry of its cell-cultured human milk, ultimately aiming to provide parents with greater flexibility and nutritional choice.

See full Biomilq company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Building MaterialsManufacturingRetailHome Improvement & Hardware RetailIndustrial Machinery & Equipment
Building MaterialsManufacturingArchitecture, Engineering & DesignConstruction ManagementConstructionIndustrial Machinery & Equipment
ManufacturingPlastic, Packaging & Containers
Food & BeverageManufacturingRetailGrocery Retail

Frequently Asked Questions Regarding Biomilq Financial Insights

What are the most recent funding rounds that Biomilq has completed, and what were the funding rounds?
Biomilq has recently completed 2 funding rounds: Series A on Oct 20, 2021, Angel/Seed on Jun 16, 2020.
What is the total amount of funding Biomilq has raised to date?
Biomilq has raised a total of $24.5M in funding to date.
How many funding rounds has Biomilq completed?
Biomilq has completed 2 funding rounds.
How much funding did Biomilq raise in its most recent funding round?
Biomilq raised $21M in its most recent funding round.
Which was the largest funding round in Biomilq's history?
The largest funding round in Biomilq's history was $21M.
See more information about Biomilq